Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1969 1
1970 1
1971 2
1972 1
1973 3
1974 4
1975 5
1976 4
1977 5
1978 2
1979 2
1980 2
1981 1
1982 5
1983 2
1984 3
1985 3
1986 5
1987 2
1988 5
1989 2
1990 8
1991 4
1992 7
1993 6
1994 5
1995 5
1996 8
1997 9
1998 3
1999 8
2000 5
2001 5
2002 9
2003 9
2004 5
2005 12
2006 15
2007 7
2008 10
2009 8
2010 8
2011 5
2012 1
2013 2
2014 3
2015 5
2016 3
2017 1
2019 1
2020 3
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

233 results
Results by year
Filters applied: . Clear all
Page 1
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
Cortes J, O'Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, Chollet P, Manikas A, Diéras V, Delozier T, Vladimirov V, Cardoso F, Koh H, Bougnoux P, Dutcus CE, Seegobin S, Mir D, Meneses N, Wanders J, Twelves C; EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389) investigators. Cortes J, et al. Among authors: chollet p. Lancet. 2011 Mar 12;377(9769):914-23. doi: 10.1016/S0140-6736(11)60070-6. Epub 2011 Mar 2. Lancet. 2011. PMID: 21376385 Clinical Trial.
[Digestive oncology: surgical practices].
Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. Slim K, et al. Among authors: chollet p. J Chir (Paris). 2009 May;146 Suppl 2:S11-80. doi: 10.1016/S0021-7697(09)72398-1. J Chir (Paris). 2009. PMID: 19435621 Review. French. No abstract available.
Neoadjuvant endocrine therapy in breast cancer.
Abrial C, Mouret-Reynier MA, Curé H, Feillel V, Leheurteur M, Lemery S, Le Bouëdec G, Durando X, Dauplat J, Chollet P. Abrial C, et al. Among authors: chollet p. Breast. 2006 Feb;15(1):9-19. doi: 10.1016/j.breast.2005.07.009. Epub 2005 Oct 17. Breast. 2006. PMID: 16230013 Review.
Methionine dependency and cancer treatment.
Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. Cellarier E, et al. Among authors: chollet p. Cancer Treat Rev. 2003 Dec;29(6):489-99. doi: 10.1016/s0305-7372(03)00118-x. Cancer Treat Rev. 2003. PMID: 14585259 Review.
[Therapeutic potential of melatonin in cancer treatment].
Abrial C, Kwiatkowski F, Chevrier R, Gachon F, Curé H, Chollet P. Abrial C, et al. Among authors: chollet p. Pathol Biol (Paris). 2005 Jun;53(5):265-8. doi: 10.1016/j.patbio.2004.12.009. Epub 2005 Jan 20. Pathol Biol (Paris). 2005. PMID: 15939135 Review. French.
[Stress, cancer and circadian rhythm of melatonin].
Kwiatkowski F, Abrial C, Gachon F, Chevrier R, Curé H, Chollet P. Kwiatkowski F, et al. Among authors: chollet p. Pathol Biol (Paris). 2005 Jun;53(5):269-72. doi: 10.1016/j.patbio.2004.12.018. Epub 2005 Jan 20. Pathol Biol (Paris). 2005. PMID: 15939136 Review. French.
[Methionine dependency of cancer cells: a new therapeutic approach?].
Durando X, Thivat E, Gimbergues P, Cellarier E, Abrial C, Dib M, Tacca O, Chollet P. Durando X, et al. Among authors: chollet p. Bull Cancer. 2008 Jan;95(1):69-76. doi: 10.1684/bdc.2008.0550. Bull Cancer. 2008. PMID: 18230572 Free article. Review. French.
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer.
Passildas-Jahanmohan J, Eymard JC, Pouget M, Kwiatkowski F, Van Praagh I, Savareux L, Atger M, Durando X, Abrial C, Richard D, Ginzac Couvé A, Thivat E, Monange B, Chollet P, Mahammedi H. Passildas-Jahanmohan J, et al. Among authors: chollet p. Cancer Med. 2021 Apr;10(7):2332-2340. doi: 10.1002/cam4.3806. Epub 2021 Mar 5. Cancer Med. 2021. PMID: 33666378 Free PMC article. Clinical Trial.
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Wang-Lopez Q, Chalabi N, Abrial C, Radosevic-Robin N, Durando X, Mouret-Reynier MA, Benmammar KE, Kullab S, Bahadoor M, Chollet P, Penault-Llorca F, Nabholtz JM. Wang-Lopez Q, et al. Among authors: chollet p. Crit Rev Oncol Hematol. 2015 Jul;95(1):88-104. doi: 10.1016/j.critrevonc.2015.02.011. Epub 2015 Mar 4. Crit Rev Oncol Hematol. 2015. PMID: 25900915 Review.
233 results